Makers Laboratories Stock Screener | Share Price & Fundamental Analysis
MAKERSL
Pharmaceuticals
Screen Makers Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹116.30
▲
2.20 (1.93%)
Market Cap
₹67.83 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.01
EPS (TTM)
₹12.70
Dividend Yield
-
Debt to Equity
0.22
52W High
₹186.45
52W Low
₹112.05
Operating Margin
9.00%
Profit Margin
5.88%
Revenue (TTM)
₹34.00
EBITDA
₹3.00
Net Income
₹2.00
Total Assets
₹148.00
Total Equity
₹115.00
Makers Laboratories Share Price History - Stock Screener Chart
Screen MAKERSL historical share price movements with interactive charts. Analyze price trends and patterns.
Makers Laboratories Company Profile - Fundamental Screener
Screen Makers Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MAKERSL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE987A01010
Makers Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen MAKERSL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 148 | 161 | 152 | 144 | 136 |
| Current Assets | 68 | 70 | 63 | 63 | 61 |
| Fixed Assets | 74 | 87 | 85 | 68 | 71 |
| Liabilities | |||||
| Total Liabilities | 148 | 161 | 152 | 144 | 136 |
| Current Liabilities | 12 | 20 | 15 | 13 | 17 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 115 | 104 | 110 | 98 | 87 |
| Share Capital | 6 | 6 | 6 | 5 | 5 |
| Reserves & Surplus | 65 | 57 | 63 | 55 | 49 |
Screen MAKERSL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 34 | 35 | 35 | 28 | 30 | 40 | 29 | 30 | 25 | 26 | 27 | 28 | 27 | 27 | 20 |
| Expenses | 31 | 32 | 32 | 27 | 29 | 27 | 26 | 28 | 25 | 25 | 26 | 25 | 25 | 25 | 20 |
| EBITDA | 3 | 3 | 3 | 1 | 1 | 13 | 2 | 2 | 0 | 1 | 1 | 3 | 1 | 3 | 0 |
| Operating Profit % | 9.00% | 9.00% | 7.00% | 3.00% | 3.00% | 7.00% | 5.00% | 6.00% | -1.00% | 1.00% | 1.00% | 7.00% | 0.00% | 6.00% | -1.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 |
| Profit Before Tax | 2 | 2 | 1 | 0 | -1 | 11 | 1 | 1 | -1 | -1 | -1 | 1 | 0 | 0 | -2 |
| Tax | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Net Profit | 2 | 1 | 1 | -1 | -1 | 10 | 0 | 0 | -2 | -1 | -1 | 1 | -1 | 0 | -2 |
| EPS | -0.08 | 0.74 | -0.20 | -2.18 | -1.67 | 14.94 | -0.50 | -0.43 | -3.55 | -2.27 | -2.61 | -1.24 | -2.82 | -1.00 | -3.65 |
Makers Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen MAKERSL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
| Operating Activities | -4 | 1 | -9 | 19 | 0 |
| Investing Activities | 20 | -7 | 1 | -22 | 0 |
| Financing Activities | -16 | 6 | 6 | 0 | 0 |
| Net Cash Flow | 0 | 0 | -2 | -3 | 0 |
Screen MAKERSL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 61.27% | 61.27% | 61.27% | 61.27% | 61.27% | 61.27% | 61.27% | 61.27% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.39% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 30.90% | 31.01% | 30.98% | 29.93% | 30.54% | 30.86% | 30.67% | 29.80% |
| Other Holding | 7.43% | 7.33% | 7.36% | 8.40% | 7.80% | 7.48% | 7.67% | 8.93% |
| Shareholder Count | 4,135 | 4,073 | 4,026 | 4,176 | 4,090 | 4,008 | 4,031 | 4,483 |
Makers Laboratories Dividend Screener - Share Yield Analysis
Screen MAKERSL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.00 | 3.50% |
| 2018-March | ₹1.00 | 1.98% |
| 2017-March | ₹1.00 | 1.42% |
| 2016-March | ₹0.00 | 0.00% |
Makers Laboratories Index Membership - Market Screener Classification
Screen MAKERSL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Makers Laboratories Market Events Screener - Corporate Actions
Screen MAKERSL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -2.41% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | 1.04% |
| 2025-08-08 | 2025-08-08 | Annual General Meeting | NA | 3.91% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | 17.74% |
| 2025-01-29 | 2025-01-29 | Quarterly Result Announcement | NA | -4.56% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | -4.57% |
| 2024-08-06 | 2024-08-06 | Annual General Meeting | NA | 25.61% |
| 2022-03-30 | 2022-04-01 | Rights | 1:5 | -2.95% |
Makers Laboratories Competitors Screener - Peer Comparison
Screen MAKERSL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 423,483 | 39.93 | 54,729 | 9.71% | 10,980 | 42.57 |
| Divis Laboratories | 172,860 | 69.20 | 9,712 | 18.67% | 2,191 | 54.31 |
| Torrent Pharmaceuticals | 129,083 | 60.10 | 11,539 | 6.99% | 1,911 | 59.28 |
| Cipla | 122,076 | 22.55 | 28,410 | 7.12% | 5,291 | 51.13 |
| Dr Reddys Laboratories | 107,031 | 18.60 | 33,741 | 16.73% | 5,725 | 57.95 |
| Lupin | 96,928 | 22.34 | 22,910 | 13.74% | 3,306 | 65.19 |
| Zydus Life Science | 92,553 | 18.40 | 23,511 | 18.55% | 4,615 | 40.83 |
| Mankind Pharma | 89,849 | 50.59 | 12,744 | 20.90% | 2,007 | 42.47 |
| Aurobindo Pharma | 71,410 | 20.79 | 32,346 | 9.43% | 3,484 | 60.10 |
| Alkem Laboratories | 67,542 | 27.59 | 13,458 | 3.70% | 2,216 | 43.27 |
Makers Laboratories Company Announcements - News Screener
Screen MAKERSL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-18 | Re-Lodgement Of Transfer Requests Of Physical Shares Report - October 2025 | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-07 | Standalone And Consolidated Financial Results For Q2 And Half Year Ended 30.09.2025 | View |
| 2025-11-07 | Board Meeting Outcome for Standalone And Consolidated Financial Results For Q2 And Half Year Ended 30.09.2025 | View |
| 2025-10-16 | Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 2Nd Quarter And Half Year Ended 30.09.2025 | View |
| 2025-10-10 | Relodgement Of Transfer For Physical Shares - Sep 2025 | View |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-25 | Closure of Trading Window | View |
| 2025-09-10 | Relodgement Of Transfer Requests Of Physical Shares - July 2025 And August 2025 | View |
| 2025-09-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-29 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-08-22 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-08-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-08 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-08-08 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-08-08 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-08-08 | Standalone And Consolidated Unaudited Financial Results For Q1FY26 | View |
| 2025-08-08 | Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results For Q1FY26 | View |
| 2025-07-25 | Board Meeting Intimation for Standalone And Consolidated Financial Results For Q1FY26 | View |
| 2025-07-14 | Intimation To Shareholders Whose E-Mail Ids Are Not Registered With The Company / RTA / DP | View |